Clinical Blogs

The myMatrixx team enjoyed connecting with prospects, clients and more at this year's conference. Read our highlights from NWCDC 2022!

When it is time to switch to a new pharmacy benefits manager (PBM), implementation becomes priority number one as a smooth implementation can make the difference in achieving real value for your program. Glean key questions from Joel Playford, myMatrixx VP of Implementations, when considering switching PBMs to help you and your team prepare for a smooth and productive implementation process.

Claims professionals have more on their plate than ever before, juggling complex decisions that impact patient care, cost efficiency, and regulatory compliance.

In the workers' comp industry, legacy claims (also known as "old dog" claims" can be difficult to manage and costly for claims professionals. Read our latest blog to learn how to effectively manage inherited legacy claims, get ahead of claim with proactive strategies and how myMatrixx's Legacy Claims' program made a vital difference for one of its clients.

Two years on, the COVID-19 pandemic continues to impact society, including our injured workforce. While patients with compensable work-related COVID-19 claims face many of the same obstacles as the broader patient population, stakeholders in the industry should be aware of several unique considerations.

A recent study shows how pharmacists play an integral role in our health care with continued evolvement to meet the growing need for access to quality care.

In observing International Overdose Awareness Day (August 31), myMatrixx parent company, Cigna, gathered several facts related to drug overdoses that affects everyone worldwide.

In this blog, we take a look at four areas that the workers' compensation industry forecasted emergent issues before they impacted general health care.

As the pharmaceutical industry continues to take on an expanding role in the development of breakthrough medication, pharmacy solutions organizations will be just as essential in ensuring their successful delivery.

One result of the pandemic that surprised many in our field last year was the limited impact of COVID-19 treatment on retail pharmacy spend.